PHYSICIAN PORTAL: PROACT

KEY INFORMATION

Simple in design and practical in its application, the ProACT™ system is an alternative surgical treatment option to consider for all severities of stress urinary incontinence. Below are key device elements of ProACT. We encourage you to browse through the contents of this page to get more in-depth information on all things ProACT. If you’re looking to speak directly with a Uromedica Representative, click on the button below to send us a message. A Uromedica representative will respond in a timely manner.

KEY DEVICE ELEMENTS:

  • Adjustable to meet each patient’s needs

  • Minimally invasive procedure

  • 20 to 30-minute procedure

  • Passive Therapy

  • Indicated for all severities of SUI (mild, moderate, and severe)

  • Can be implanted if patient has a failed AUS or Sling

PROCEDURE INFORMATION

GENERAL SAFETY INFORMATION

REIMBURSEMENT INFORMATION

COMPARE YOUR OPTIONS

PUBLICATIONS + UROMEDICA IN THE NEWS:

 

There are over 40+ publications on the ProACT system. The following are some of the most recent and up to date publications available. 

Outcome and complications of adjustable continence therapy (ProACTtm) in the treatment of urinary incontinence after transurethral resection of the prostate: A multicenter study

Noordhoff et al

Neurourology and Urodynamics. 2019;1‐9.

https://doi.org/10.1002/nau.23966

Adjustable continence therapy (ProACTtm) for the treatment of male stress urinary incontinence: A systematic review and meta-analysis

Larson T. et al

Neurourology and Urodynamics. 2019;1‐9. 

https://doi.org/10.1002/nau.24135

Efficacy and safety of adjustable balloons (ProACTtm) to treat male stress urinary incontinence after prostate surgery: Medium and long-term follow-up data of a national multicentric retrospective study

Finazzi E. et al

Neurourology and Urodynamics. 2019;1‐6.

https://doi.org/10.1002/nau.24103

Four-year follow-up on 68 patients with a new post-operatively adjustable long-term implant for post-prostatectomy stress incontinence: ProACT™.
Nash, S et al.
Neurourol Urodyn. 2019; 38(1): 248-253.
DOI: http://dx.doi.org/10.1002/nau.23838 

1840 BERKSHIRE LN N

PLYMOUTH, MN 55441

763-694-9880

  • Facebook
  • Twitter
  • YouTube